航宇微(300053.SZ):玉龍YL810A芯片成為了K間站系統中的首個人工智能硬件試驗平台採用的AI芯片
格隆匯1月18日丨航宇微(300053.SZ)在投資者關係活動上表示,2023年5月10日,長征七號遙七運載H箭搭載天舟六號貨運飛船在我國文昌航天發射場發射升空,其中,天舟六號貨運飛船中有一份貨物是智能試驗單元,該單元採用了公司的玉龍YL810A人工智能芯片。該試驗單元將由航天員安裝到M天實驗艙,於在軌試驗的K間站工程運營階段首次開展核心元器件及系統的在軌試驗,已開機運行。玉龍YL810A芯片成為了K間站系統中的首個人工智能硬件試驗平台採用的AI芯片,標誌着玉龍YL810A芯片正式進入K間站在軌飛行階段。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.